Anthracycline-related cognitive dysfunction concerns disputed

The authors of a research letter find no association between anthracycline-based chemotherapy and decline in neurocognitive function among breast cancer survivors, in contrast to another recent study.
Source: MedWire News - Category: Consumer Health News Tags: Breast cancer Source Type: news